Breast cancer in young women is a devastating and complex disease. Breast cancer in women under 40 strikes when these women are at the peak of their reproductive years, family life and careers and still have many years ahead of them to suffer the long-term effects of treatment or the consequences of recurrent disease. The etiology of breast cancer in this population is poorly understood and most clinical trials focus on women who are over the age of 40, thus little evidence-based data is available about the optimal management of these patients. Further research is much needed in this field. This conference is an opportunity for the latest updates on this field and a platform for generating future research concepts and collaborations. It will cover epidemiology, molecular biology, genetics, pathology, surgery, radiotherapy, systemic therapy and fertility preservation in young women with breast cancer.

LEARNING OBJECTIVES

• In depth learning of various aspects of breast cancer in young women
• Importance of multi-disciplinary management
• Management of difficult clinical cases


MAIN TOPICS

• Hereditary breast cancer
• Diagnostic tools in young women
• Local therapy
• Systemic therapy
• Pregnancy and breast cancer
• Fertility preservation
• Psychosocial aspects
• Management of side effects
• Case discussions


TARGET AUDIENCE
• Medical oncologists
• Surgeons
• Gynaecologists
• Radiation oncologists
• Breast radiologists
• Onco-geneticists
• Phatologists
• Nurses
• Patient advocates

IMPORTANT DEADLINES

Abstracts subimission: 30 June 2014
Early Registration: by 3 August 2014
LKate Registration: by 12 October 2014


email: eso@eso.net


VENUE
Hilton Tel Aviv Hotel
Independence Park
Tel Aviv, 63405 – Israel
www.hiltontelavivhotel.com